Fundz

Ku Leuven Spin-Off Astrivax Raises € 30 Million Seed Capital To Build Vaccine Platform

PRIVATEAug 25, 2022

Amount Raised

€30 Million

Round Type

Seed

LeuvenBiotechnology

Quick answer

AstriVax raised €30 Million in a Seed round, dated August 25, 2022. AstriVax is based in Leuven, Flemish Brabant, Belgium.

How much did AstriVax raise?
AstriVax raised €30 Million in a Seed round on August 25, 2022.
What does AstriVax do?
AstriVax is a privately held spin-off company from the KU Leuven, founded in 2022 based on vaccine technology developed at the Rega Institute.
Where is AstriVax based and how big is it?
AstriVax is based in Leuven, Flemish Brabant, Belgium.
Who are the decision-makers at AstriVax?
Fundz holds 1 contact at AstriVax. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as AstriVax that raised within 45 days of this round, from Fundz verified event records.

  • Earth Science Tech raised $1.2M (Seed) on October 8, 2022.
  • Pic Therapeutics raised $6.5M on October 7, 2022.
  • RadioMedix raised $40M (Series A) on October 7, 2022.
  • NewcelX raised $4M (Seed) on October 7, 2022.
  • Replimune raised $200M (Debt Financing) on October 7, 2022.
  • Inceptor Bio raised $2.6M on October 7, 2022.

Who to call at AstriVax, and when

A new round usually means AstriVax is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day AstriVax raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at AstriVax, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at AstriVax. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

AstriVax

Location

Ambachtenlaan

Leuven, Flemish Brabant, Belgium

About

AstriVax is a privately held spin-off company from the KU Leuven, founded in 2022 based on vaccine technology developed at the Rega Institute. AstriVax is building a first in class Plug & Play vaccine platform with a patented DNA based technology that launches self-amplifying live attenuated viruses. The versatile technology of AstriVax can be used to develop a wide range of vaccines to prevent and treat infectious diseases. AstriVax aims to address major challenges in vaccinology by developing novel vaccines that are easy to produce, have reduced cold chain requirements, and offer broad and long-lasting protection against various viruses and other pathogens.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment AstriVax raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for AstriVax's next move

See what Strategic adds

AstriVax raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.